Structural analysis of CXCR4 – Antagonist interactions using saturation-transfer double-difference NMR

CXCR4 is a GPCR involved in leukocyte trafficking. Small molecule antagonists of the receptor may treat inflammatory disease, cancer and HIV. Here we probe the binding of a tetrahydroisoquinoline-based antagonist (TIQ-10) to CXCR4 using saturation transfer double-difference (STDD) NMR. STDD spectra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2015-10, Vol.466 (1), p.28-32
Hauptverfasser: Cox, Bryan D., Mehta, Anil K., DiRaddo, John O., Liotta, Dennis C., Wilson, Lawrence J., Snyder, James P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:CXCR4 is a GPCR involved in leukocyte trafficking. Small molecule antagonists of the receptor may treat inflammatory disease, cancer and HIV. Here we probe the binding of a tetrahydroisoquinoline-based antagonist (TIQ-10) to CXCR4 using saturation transfer double-difference (STDD) NMR. STDD spectra were acquired using extracts from Chinese Hamster Ovary cells expressing membrane-embedded CXCR4. The experiments demonstrate competitive binding between TIQ-10 and established antagonists and provide the TIQ-10 – CXCR4 binding epitope. Molecular modeling of TIQ-10 into the binding pocket provides a pose consistent with STDD-derived interactions. This study paves the way for future investigations of GPCR-ligand interactions in a biological milieu for use in chemical biology, biochemistry, structural biology, and rational drug design. [Display omitted] •Saturation transfer difference NMR for antagonists bound to the CXCR4 receptor in cellular membrane extracts is presented.•Competitive binding between two CXCR4 antagonists using STD NMR is established.•The STD-NMR binding epitope of a small molecule CXCR4 antagonist is identified.•A 3D model consistent with the experimentally-derived epitope is proposed.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2015.08.084